138 related articles for article (PubMed ID: 2220941)
41. The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man.
Bentsen KD; Lanng C; Hørslev-Petersen K; Risteli J
Acta Chir Scand; 1988 Feb; 154(2):97-101. PubMed ID: 3354300
[TBL] [Abstract][Full Text] [Related]
42. Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders.
Hørslev-Petersen K; Bentsen KD; Junker P; Mathiesen FK; Hansen TM; Lorenzen I
Clin Rheumatol; 1988 Mar; 7(1):61-8. PubMed ID: 3261674
[TBL] [Abstract][Full Text] [Related]
43. Increased serum procollagen III aminoterminal peptide in myelofibrosis.
Hochweiss S; Fruchtman S; Hahn EG; Gilbert H; Donovan PB; Johnson J; Goldberg JD; Berk PD
Am J Hematol; 1983 Dec; 15(4):343-51. PubMed ID: 6650494
[TBL] [Abstract][Full Text] [Related]
44. Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum.
Koivula MK; Risteli L; Risteli J
Clin Biochem; 2012 Aug; 45(12):920-7. PubMed ID: 22480789
[TBL] [Abstract][Full Text] [Related]
45. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of high-risk pregnancies: a biochemical approach to the dynamic assessment of deviant fetal growth.
Vanhaesebrouck P; Kint J; Van Kets H; Govaert P; Smets K; Defoort P; Leroy J
Pediatr Res; 1994 Jul; 36(1 Pt 1):71-6. PubMed ID: 7936841
[TBL] [Abstract][Full Text] [Related]
46. Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease.
Hayasaka A; Schuppan D; Ohnishi K; Okuda K; Hahn EG
J Hepatol; 1990 Jan; 10(1):17-22. PubMed ID: 2307825
[TBL] [Abstract][Full Text] [Related]
47. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
Zachariae H; Halkier-Sørensen L; Heickendorff L
Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
[TBL] [Abstract][Full Text] [Related]
48. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
[TBL] [Abstract][Full Text] [Related]
49. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of appropriate-for-gestational-age infants: a predictor of age-related fetal growth rate.
Vanhaesebrouck P; Kint J; Dhont M; De Praeter C; Leroy J
Pediatr Res; 1994 Jul; 36(1 Pt 1):64-70. PubMed ID: 7936839
[TBL] [Abstract][Full Text] [Related]
50. Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomas.
Wiklund TA; Blomqvist CP; Risteli L; Risteli J; Elomaa I
J Cancer Res Clin Oncol; 1993; 119(3):160-4. PubMed ID: 8418089
[TBL] [Abstract][Full Text] [Related]
51. [Level of aminoterminal type 1 procollagen propeptide--the bone formation marker--in the sera of healthy males].
Ermakova IP; Buzulina VP; Pronchenko IA; Dudov NS; Mininkov AS; Ponkratova TS
Klin Lab Diagn; 2007 May; (5):13-5. PubMed ID: 17668457
[TBL] [Abstract][Full Text] [Related]
52. Aminoterminal propeptide of type III procollagen reflects formation of collagen following rejection after heart transplantation.
Høst NB; Aldershvile J; Jensen LT; Mortensen SA; Pettersson G; Høyer S; Haunsø S
Transplant Proc; 1994 Jun; 26(3):1813. PubMed ID: 8030150
[No Abstract] [Full Text] [Related]
53. Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer.
Santala M; Risteli J; Risteli L; Puistola U; Kacinski BM; Stanley ER; Kauppila A
Br J Cancer; 1998 Jun; 77(11):1825-31. PubMed ID: 9667653
[TBL] [Abstract][Full Text] [Related]
54. Glucocorticoids inhibit the synthesis rate of type III collagen, but do not affect the hepatic clearance of its aminoterminal propeptide (PIIINP).
Hansen M; Stoltenberg M; Høst NB; Boesby S; Lorenzen I; Bentsen KD
Scand J Clin Lab Invest; 1995 Oct; 55(6):543-8. PubMed ID: 8571085
[TBL] [Abstract][Full Text] [Related]
55. Serum interleukin-6 level in patients with systemic sclerosis: lack of correlation with aminoterminal propeptide of type III procollagen.
Kucharz EJ; Jonderko G; Rubisz-Brzezinska J; Brzezinska-Wcisło L
Clin Rheumatol; 1995 May; 14(3):380-1. PubMed ID: 7641522
[No Abstract] [Full Text] [Related]
56. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions.
Gressner AM; Tittor W; Negwer A
Hepatogastroenterology; 1986 Oct; 33(5):191-5. PubMed ID: 3804173
[TBL] [Abstract][Full Text] [Related]
57. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle.
Gorai I; Taguchi Y; Chaki O; Kikuchi R; Nakayama M; Yang BC; Yokota S; Minaguchi H
J Clin Endocrinol Metab; 1998 Feb; 83(2):326-32. PubMed ID: 9467535
[TBL] [Abstract][Full Text] [Related]
58. Procollagen type III amino-terminal propeptide: a serum biomarker of left ventricular remodelling in paediatric dilated cardiomyopathy.
Kaufman BD; Videon N; Zhang X; Harris MA; Shaddy RE; Goldmuntz E
Cardiol Young; 2015 Feb; 25(2):228-36. PubMed ID: 24192074
[TBL] [Abstract][Full Text] [Related]
59. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
60. Aminoterminal propeptide of type III procollagen in healing wound in humans.
Haukipuro K; Risteli L; Kairaluoma MI; Risteli J
Ann Surg; 1987 Dec; 206(6):752-6. PubMed ID: 3689011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
